AFP and hepatocellular carcinoma: A total of 199 HCC patients with AFP-negative were included in this study, these patients were divided randomly into a training dataset (n = 139, including 50 patients with early recurrence) and a validation dataset (n = 60, including 25 patients with early recurrence) at a ratio 7:3 (Table 2).